Cargando…
Hsa-miR-202-3p, up-regulated in type 1 gastric neuroendocrine neoplasms, may target DUSP1
AIM: To detect abnormal microRNA (miRNA) expression in type 1 gastric neuroendocrine neoplasms (g-NENs) and find potential target genes. METHODS: Tumour tissues from patients with type 1 g-NENs were used as experimental samples, and gastric mucosal tissues from the same patients obtained during gast...
Autores principales: | Dou, Dou, Shi, Yan-Fen, Liu, Qing, Luo, Jie, Liu, Ji-Xi, Liu, Meng, Liu, Ying-Ying, Li, Yuan-Liang, Qiu, Xu-Dong, Tan, Huang-Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5799858/ https://www.ncbi.nlm.nih.gov/pubmed/29434446 http://dx.doi.org/10.3748/wjg.v24.i5.573 |
Ejemplares similares
-
Circulating miRNA-202-3p is a potential novel biomarker for diagnosis of type 1 gastric neuroendocrine neoplasms
por: Dou, Dou, et al.
Publicado: (2021) -
Clinical significance of programmed death 1/programmed death ligand 1 pathway in gastric neuroendocrine carcinomas
por: Yang, Min-Wei, et al.
Publicado: (2019) -
Aberrant DNA-PKcs and ERGIC1 expression may be involved in initiation of gastric cancer
por: Wang, Fu-Rong, et al.
Publicado: (2017) -
Hsa_circ_0017728 as an oncogene in gastric cancer by sponging miR-149 and modulating the IL-6/STAT3 pathway
por: Yang, Chun, et al.
Publicado: (2019) -
Decrease of miR-202-3p Expression, a Novel Tumor Suppressor, in Gastric Cancer
por: Zhao, Yu, et al.
Publicado: (2013)